Cogstate Limited (COGZF)
COGZF Stock Price Chart
Explore Cogstate Limited interactive price chart. Choose custom timeframes to analyze COGZF price movements and trends.
COGZF Company Profile
Discover essential business fundamentals and corporate details for Cogstate Limited (COGZF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
IPO Date
5 Apr 2010
Employees
147.00
Website
https://www.cogstate.comCEO
Bradley John O'Connor CA
Description
Cogstate Limited, a neuroscience technology company, provides computerized cognitive tests and electronic clinical outcome assessment solutions. The company's cognitive services include project management, data management, scientific consulting, statistical analysis, scales procurement, rater training, and monitoring solutions. It operates in Clinical Trials and Healthcare segments. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of diseases and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Healthcare segment provides Cognigram, a system for regular and standardized testing to assist primary care physicians and/or hospitals in the early detection of cognitive decline. As of June 30, 2022, it had participated in approximately 1,800 academic research. Cogstate Limited was incorporated in 1999 and is based in Melbourne, Australia.
COGZF Financial Timeline
Browse a chronological timeline of Cogstate Limited corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Feb 2026
Dividend declared on 27 Aug 2025
A dividend of $0.01 per share was announced, adjusted to $0.01. The dividend will be paid on 29 Sept 2025.
Earnings released on 22 Aug 2025
Revenue for the quarter reached $29.15M , beating expectations by +0.16%.
Earnings released on 20 Feb 2025
EPS came in at $0.02 , while revenue for the quarter reached $23.94M , beating expectations by +0.18%.
Earnings released on 21 Aug 2024
EPS came in at $0.02 , while revenue for the quarter reached $23.25M , beating expectations by +5.68%.
Earnings released on 21 Feb 2024
EPS came in at $0.01 , while revenue for the quarter reached $18.84M , missing expectations by -3.37%.
Earnings released on 30 Jun 2023
EPS came in at $0.02 , while revenue for the quarter reached $22.63M , beating expectations by +16.04%.
Earnings released on 31 Dec 2022
EPS came in at $0.00 , while revenue for the quarter reached $17.79M , missing expectations by -7.36%.
Earnings released on 30 Jun 2022
EPS came in at $0.02 falling short of the estimated $0.02 by -7.51%, while revenue for the quarter reached $22.97M , beating expectations by +4.88%.
Earnings released on 31 Dec 2021
EPS came in at $0.02 , while revenue for the quarter reached $20.77M , missing expectations by -10.08%.
Earnings released on 30 Jun 2021
EPS came in at $0.03 , while revenue for the quarter reached $19.13M .
Earnings released on 31 Dec 2020
EPS came in at -$0.00 , while revenue for the quarter reached $13.83M .
COGZF Stock Performance
Access detailed COGZF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.